Featured Headlines Feed for HEB Headlines for Hemispherx BioPharma, Inc. http://www.rssboard.org/rss-specification Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic The 5 Dumbest Things on Wall Street This Week: May 3 http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11913184/1/the-5-dumbest-things-on-wall-street-this-week-may-3.html.aspx?puc=aol&cm_ven=aol&source=itxwebtxt0000015 TheStreet Fri, 03 May 2013 08:21:00 GMT An Outrageous, Shameless Act by Hemispherx's Board of Directors http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11910992/1/an-outrageous-shameless-act-by-hemispherxs-board-of-directors.html.aspx?puc=aol&cm_ven=aol&source=itxwebtxt0000015 TheStreet Wed, 01 May 2013 12:03:00 GMT Biotechs Ramping Up On China's Avian Flu Outbreak http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1325891-biotechs-ramping-up-on-china-s-avian-flu-outbreak.aspx?source=itxwebtxt0000015 Seeking Alpha Mon, 08 Apr 2013 02:42:24 GMT Hemispherx Wins Broad Treatment Expansion for Alferon N Injection in Argentina http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3385658/hemispherx-wins-broad-treatment-expansion-for-alferon-n-injection-in-argentina.aspx?source=itxwebtxt0000015 Benzinga Mon, 04 Mar 2013 08:08:22 GMT UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Hemispherx http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/20/upcoming-deadline-levi-korsinsky-notifies-investor/.aspx?source=itxwebtxt0000015 DailyFinance Wed, 20 Feb 2013 16:04:15 GMT U.S. HOT STOCKS: Zynga, Take-Two, Shutterfly Active in Late Trading http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130205-000557&cid=1244&source=itxwebtxt0000015 Smart Money Tue, 05 Feb 2013 18:26:59 GMT U.S. HOT STOCKS: Yum Brands, McGraw-Hill, Virgin Media, Opexa http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130205-000423&cid=1244&source=itxwebtxt0000015 Smart Money Tue, 05 Feb 2013 14:05:59 GMT Hemispherx's Chronic Fatigue Drug Rejected by FDA http://www.fool.com/news/xt/minyanville/www.minyanville.com/sectors/biotech-pharma/articles/hemispherx2527s-chronic-fatigue-drug-rejected-by/2/5/2013/id/47889.aspx?source=itxwebtxt0000015 Minyanville Tue, 05 Feb 2013 09:30:00 GMT Hemispherx says FDA rejects fatigue drug application http://www.fool.com/news/xt/reuters/www.reuters.com/article/marketsnews/idusl4n0b511u20130205.aspx?source=itxwebtxt0000015 Reuters Mon, 04 Feb 2013 21:22:06 GMT Biotech Stock Mailbag: Celsion, Navidea, AP Pharma, Sarepta http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11828743/1/biotech-stock-mailbag-celsion-navidea-ap-pharma-sarepta.html.aspx?puc=aol&cm_ven=aol&source=itxwebtxt0000015 TheStreet Fri, 01 Feb 2013 07:00:00 GMT Four Closely Watched Drug Decisions Loom in February http://www.fool.com/news/xt/minyanville/www.minyanville.com/sectors/biotech-pharma/articles/5-high-profile-drugs-expect-fda/1/31/2013/id/47803.aspx?source=itxwebtxt0000015 Minyanville Thu, 31 Jan 2013 14:45:00 GMT 5 High-Profile Drugs Expect FDA Decisions in February http://www.fool.com/news/xt/minyanville/www.minyanville.com/sectors/biotech-pharma/articles/5-high-profile-drugs-expect-fda/1/31/2013/id/47803.aspx?source=itxwebtxt0000015 Minyanville Thu, 31 Jan 2013 14:45:00 GMT Hemispherx Biopharma Says FDA Panel Voted 9-4 Against Ampligen Effocacy http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/12/12/3195372/hemispherx-biopharma-says-fda-panel-voted-9-4-against-ampligen-effocacy.aspx?source=itxwebtxt0000015 Benzinga Fri, 21 Dec 2012 15:00:42 GMT 2 Biotech Stocks That Could Be Prime Candidates For The Short Seller http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1077461-2-biotech-stocks-that-could-be-prime-candidates-for-the-short-seller.aspx?source=itxwebtxt0000015 Seeking Alpha Fri, 21 Dec 2012 11:18:24 GMT Hemispherx BioPharma Soars Then Plunges as FDA Panel Votes Against Ampligen Approval http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/12/12/3192288/hemispherx-biopharma-soars-then-plunges-as-fda-panel-votes-against-ampligen-appro.aspx?source=itxwebtxt0000015 Benzinga Thu, 20 Dec 2012 18:09:21 GMT Stock Watch Wednesday, 19 December http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1072781-stock-watch-wednesday-19-december.aspx?source=itxwebtxt0000015 Seeking Alpha Wed, 19 Dec 2012 09:24:10 GMT Hemispherx Faces FDA Day http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1072481-hemispherx-faces-fda-day.aspx?source=itxwebtxt0000015 Seeking Alpha Wed, 19 Dec 2012 06:51:08 GMT Hemispherx's Unsurprising 45% Plunge http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2012/12/18/hemispherxs-unsurprising-45-plunge/.aspx?source=itxwebtxt0000015 DailyFinance Tue, 18 Dec 2012 16:14:00 GMT Hemispherx Chronic Fatigue Drug Scrutinized Ahead of Panel Review http://www.fool.com/news/xt/minyanville/www.minyanville.com/sectors/biotech-pharma/articles/hemispherx-chronic-fatigue-drug-scrutinized-ahead/12/18/2012/id/46783.aspx?source=itxwebtxt0000015 Minyanville Tue, 18 Dec 2012 12:33:00 GMT Strong Small Cap Biopharma Catalyst Trades And Investments For Consideration http://www.fool.com/news/xt/trefis/www.trefis.com/stock/arql/articles/159178/strong-small-cap-biopharma-catalyst-trades-and-investments-for-consideration/2012-12-18.aspx?source=itxwebtxt0000015 Trefis Tue, 18 Dec 2012 11:36:07 GMT